Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial — Dick de Zeeuw (2010) | RDL Network
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
Hiddo J.L. Heerspink, Rajiv Agarwal, Daniel W. Coyne, H.‐H. Parving, Eberhard Ritz, Giuseppe Remuzzi, Paul Audhya, Michael Amdahl, D.L. Andress, Dick de Zeeuw
Aneliya Parvanova, Matias Trillini, Manuel Alfredo Podestà, Ilian Iliev, Barbara Ruggiero, Manuela Abbate, Annalisa Perna, Francesco Peraro, Olimpia Diadei, Nadia Rubis, Flavio Gaspari, Fabiola Carrara, Nadia Stucchi, Antonio Belviso, Antonio Bossi, Roberto Trevisan, Giuseppe Remuzzi, Martin H. de Borst, Piero Ruggenenti, Norberto Perico, Piero Ruggenenti, Giuseppe Remuzzi, Stefano Rota, Matias Trillini, Barbara Ruggiero, M Aparicio, Silvia Prandini, Daniela Cugini, Giulia Gherardi, Manuel Alfredo Podestà, Roberto Trevisan, A. Corsi,
Khalid M. Alkharfy, Nasser M. Al‐Daghri, Shaun Sabico, Abdulaziz M. Al-Othman, Osama Moharram, Majed S. Alokail, Yousef Al‐Saleh, Sudhesh Kumar, George Chrousos
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.